Loading...
ETFMG Treatments, Testing and Advancements ETF
GERM•AMEX
Financial ServicesAsset Management
$19.16
$-0.06(-0.29%)
ETFMG Treatments, Testing and Advancements ETF (GERM) Stock Overview
Explore ETFMG Treatments, Testing and Advancements ETF’s financial performance, market position, analyst ratings, and future outlook.
Stats data is not available for GERMStats details for GERM are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for GERMAnalyst Recommendations details for GERM are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Company Profile
The index tracks the performance of U.S.-listed equity securities or depositary receipts of companies that (i) perform research, development, and commercialization of treatments or vaccines for infectious diseases or (ii) engage in the research, development, manufacturing, and provision of biological tests for patients. The fund invests at least 80% of its total assets in the component securities of the index. The fund is non-diversified.
Headquarters
DE
Founded
2020